135 related articles for article (PubMed ID: 3447935)
1. Pharmacokinetics of orally administered tizanidine in healthy volunteers.
Tse FL; Jaffe JM; Bhuta S
Fundam Clin Pharmacol; 1987; 1(6):479-88. PubMed ID: 3447935
[TBL] [Abstract][Full Text] [Related]
2. Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.
Granfors MT; Backman JT; Neuvonen M; Ahonen J; Neuvonen PJ
Clin Pharmacol Ther; 2004 Apr; 75(4):331-41. PubMed ID: 15060511
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of PN 200-110 (isradipine), a new calcium antagonist, after oral administration in man.
Tse FL; Jaffe JM
Eur J Clin Pharmacol; 1987; 32(4):361-5. PubMed ID: 2956112
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic characterization of tizanidine nasal spray, a novel intranasal delivery method for the treatment of skeletal muscle spasm.
Vitale DC; Piazza C; Sinagra T; Urso V; Cardì F; Drago F; Salomone S
Clin Drug Investig; 2013 Dec; 33(12):885-91. PubMed ID: 24085590
[TBL] [Abstract][Full Text] [Related]
5. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
Shah J; Wesnes KA; Kovelesky RA; Henney HR
Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers.
Tse FL; Jaffe JM; Troendle A
J Clin Pharmacol; 1992 Jul; 32(7):630-8. PubMed ID: 1640002
[TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Henney HR; Shah J
Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
[TBL] [Abstract][Full Text] [Related]
8. The sedative and sympatholytic effects of oral tizanidine in healthy volunteers.
Miettinen TJ; Kanto JH; Salonen MA; Scheinin M
Anesth Analg; 1996 Apr; 82(4):817-20. PubMed ID: 8615503
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.
Granfors MT; Backman JT; Neuvonen M; Neuvonen PJ
Clin Pharmacol Ther; 2004 Dec; 76(6):598-606. PubMed ID: 15592331
[TBL] [Abstract][Full Text] [Related]
10. Modified release tizanidine: a review.
Hutchinson DR
J Int Med Res; 1989; 17(6):565-73. PubMed ID: 2697626
[TBL] [Abstract][Full Text] [Related]
11. Biological fate of sirdalud in animals and man.
Koch P; Hirst DR; von Wartburg BR
Xenobiotica; 1989 Nov; 19(11):1255-65. PubMed ID: 2618078
[TBL] [Abstract][Full Text] [Related]
12. A controlled pharmacokinetic evaluation of tizanidine and baclofen at steady state.
Shellenberger MK; Groves L; Shah J; Novack GD
Drug Metab Dispos; 1999 Feb; 27(2):201-4. PubMed ID: 9929503
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of tizanidine.
Roberts RC; Part NJ; Pokorny R; Muir C; Leslie GC; Emre M
Neurology; 1994 Nov; 44(11 Suppl 9):S29-31. PubMed ID: 7970008
[TBL] [Abstract][Full Text] [Related]
14. Absorption, metabolism, and disposition of [14C]SDZ ENA 713, an acetylcholinesterase inhibitor, in minipigs following oral, intravenous, and dermal administration.
Tse FL; Laplanche R
Pharm Res; 1998 Oct; 15(10):1614-20. PubMed ID: 9794506
[TBL] [Abstract][Full Text] [Related]
15. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of compound 58-112, a potential skeletal muscle relaxant, in man.
Tse FL; Jaffe JM; Dain JG
J Clin Pharmacol; 1984 Jan; 24(1):47-57. PubMed ID: 6707234
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
Blight AR; Henney HR
Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
[TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of finasteride in dogs.
Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
[TBL] [Abstract][Full Text] [Related]
19. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.
Frantz SW; Ballantyne B; Leung HW
Toxicol Ind Health; 1998; 14(3):413-28. PubMed ID: 9569447
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans.
Barbhaiya RH; Dandekar KA; Greene DS
Drug Metab Dispos; 1996 Jan; 24(1):91-5. PubMed ID: 8825195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
